Volume 20, Number 3—March 2014
Dispatch
Crimean-Congo Hemorrhagic Fever among Health Care Workers, Turkey
Table 1
HCW, outcome | Body temperature, °C | Bleeding | Leukocytes/mm3 | Platelets/mm3 | AST | ALT | APTT | Fibrinogen | SSI |
---|---|---|---|---|---|---|---|---|---|
1, survived | 38.5 | No | 800 | 42,000 | 425 | 346 | 44 | 225 | Moderate |
2, survived | 37.2 | No | 1100 | 53,000 | 145 | 81 | 43 | 270 | Mild |
3, died | 40.5 | Ecchymosis, hematemesis, melena, hematuria | 11,100 | 40,000 | 251 | 277 | 90 | 171 | Severe |
4, survived | 40.5 | No | 2,900 | 78,000 | 150 | 110 | 37.4 | 250 | Mild |
5, survived | 39 | Epistaxis | 1,800 | 58,000 | 167 | 129 | 64 | 218 | Moderate |
6, survived | 40.5 | No | 1,800 | 44,000 | 123 | 216 | 40.5 | 165 | Moderate |
7, survived | 39.1 | No | 3,100 | 13,000 | 418 | 132 | 40.9 | 170 | Moderate |
*HCW, health care worker; AST, aspartate aminotransferase; ALT, alanine aminotransferase; APTT, activated partial thromboplastin time ; SSI, severity score index.
†Reference values: leukocytes, 4,000–11,000/mm3; platelets, 150,000–450,000/mm3; AST, <50 IU/L; ALT, <50 IU/L; APTT, 24–36 sec; fibrinogen, 200–400 mg/dL.
Page created: February 19, 2014
Page updated: February 19, 2014
Page reviewed: February 19, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.